Header Logo

DANIEL AYANGA

Concepts (11)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with DANIEL AYANGA's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that DANIEL AYANGA has written about over time.
Adrenergic alpha-2 Receptor Agonists, 1 publications between 2016 and 2016, average publication date October 2016. Buprenorphine, 1 publications between 2016 and 2016, average publication date October 2016. Clonidine, 1 publications between 2016 and 2016, average publication date October 2016. Combined Modality Therapy, 1 publications between 2016 and 2016, average publication date October 2016. Humans, 1 publications between 2016 and 2016, average publication date October 2016. Methadone, 1 publications between 2016 and 2016, average publication date October 2016. Naltrexone, 1 publications between 2016 and 2016, average publication date October 2016. Narcotic Antagonists, 1 publications between 2016 and 2016, average publication date October 2016. Opiate Substitution Treatment, 1 publications between 2016 and 2016, average publication date October 2016. Opioid-Related Disorders, 1 publications between 2016 and 2016, average publication date October 2016. Treatment Outcome, 1 publications between 2016 and 2016, average publication date October 2016.

To see the data from this visualization as text, click here.
AYANGA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (11)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_